Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,569 | -11,135 | -6,954 | -44,078 | -36,862 |
| Depreciation Amortization | N/A | N/A | N/A | 65 | 65 |
| Accounts receivable | 96 | 96 | N/A | 4 | -127 |
| Accounts payable and accrued liabilities | -2,157 | -1,106 | 955 | 1,142 | -183 |
| Other Working Capital | -4,651 | -2,439 | 314 | -2,850 | -1,899 |
| Other Operating Activity | -9,423 | 1,815 | -529 | 5,106 | 5,438 |
| Operating Cash Flow | $-19,704 | $-12,769 | $-6,214 | $-40,611 | $-33,568 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 10,402 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $10,402 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24 | 24 | N/A | 29 | 17 |
| Common Stock Repurchased | 5,000 | 5,000 | N/A | N/A | N/A |
| Financing Cash Flow | $5,024 | $5,024 | $N/A | $29 | $17 |
| Exchange Rate Effect | 4 | 4 | 1 | 3 | -5 |
| Beginning Cash Position | 13,382 | 13,382 | 13,382 | 53,961 | 53,961 |
| End Cash Position | 9,108 | 5,641 | 7,169 | 13,382 | 20,405 |
| Net Cash Flow | $-4,274 | $-7,741 | $-6,213 | $-40,579 | $-33,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,704 | -12,769 | -6,214 | -40,611 | -33,568 |
| Free Cash Flow | -19,704 | -12,769 | -6,214 | -40,611 | -33,568 |